Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. (abre una nueva ventana)

Evans WE, Relling MV, Rodman JH, Crom WR, Boyett JM, Pui CH

Fuente‎: N Engl J Med 1998;338(8):499-505.

Indexado en‎: PubMed 9468466

DOI‎: 10.1056/NEJM199802193380803

https://www.ncbi.nlm.nih.gov/pubmed/9468466 (abre una nueva ventana)

Childhood cancer and the Jehovah's Witness faith. (abre una nueva ventana)

Frankel LS, Damme CJ, Eys JV.

Fuente‎: Pediatrics 1977;60(6):916-21.

Indexado en‎: PubMed 600607

https://www.ncbi.nlm.nih.gov/pubmed/600607 (abre una nueva ventana)

Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma. (abre una nueva ventana)

Kushner BH, Kramer K, LaQuaglia MP, Modak S, Yataghene K, Cheung NK

Fuente‎: J Clin Oncol 2004;22(24):4888-92.

Indexado en‎: PubMed 15611504

DOI‎: 10.1200/JCO.2004.02.101

https://www.ncbi.nlm.nih.gov/pubmed/15611504 (abre una nueva ventana)

Assessment of arsenic trioxide and all-trans retinoic acid for the treatment of pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group AAML1331 Trial. (abre una nueva ventana)

Kutny MA, Alonzo TA, Abla O, Rajpurkar M, Gerbing RB, Wang YC, Hirsch BA, Raimondi S, Kahwash S, Hardy KK, Hardy S, Meshinchi S, Gamis AS, Kolb EA, Feusner JH, Gregory J Jr

Fuente‎: JAMA Oncol 2022;8(1):79-87. 

Indexado en‎: PubMed 34762093

DOI‎: 10.1001/jamaoncol.2021.5206

https://pubmed.ncbi.nlm.nih.gov/34762093/ (abre una nueva ventana)

Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia. (abre una nueva ventana)

Lou Y, Qian W, Meng H, Mai W, Tong H, Tong Y, Huang J, Jin J.

Fuente‎: Hematol Oncol 2014;32(1):40-6.

Indexado en‎: PubMed 23963734

DOI‎: 10.1002/hon.2076

https://www.ncbi.nlm.nih.gov/pubmed/23963734 (abre una nueva ventana)

Acute leukemia in Jehovah's Witnesses: a challenge for hematologists. (abre una nueva ventana)

Mazza P, Palazzo G, Amurri B, Cervellera M, Rizzo C, Maggi A

Fuente‎: Haematologica 2000;85(11):1221-2.

Indexado en‎: PubMed 11064477

https://www.ncbi.nlm.nih.gov/pubmed/11064477 (abre una nueva ventana)

Autologous and allogeneic stem cell transplant in Jehovah's Witnesses: a single-center experience on 22 patients. (abre una nueva ventana)

Mazza P, Palazzo G, Minoia C, Amurri B, Pisapia G

Fuente‎: Bone Marrow Transplant 2016;51(7):1002-3.

Indexado en‎: PubMed 26950381

DOI‎: 10.1038/bmt.2016.29

https://www.ncbi.nlm.nih.gov/pubmed/26950381 (abre una nueva ventana)

Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience. (abre una nueva ventana)

Mazza P, Prudenzano A, Amurri B, Palazzo G, Pisapia G, Stani L, Pricolo G.

Fuente‎: Bone Marrow Transplant 2003;32(4):433-6.

Indexado en‎: PubMed 12900781

DOI‎: 10.1038/sj.bmt.1704179

https://www.ncbi.nlm.nih.gov/pubmed/12900781 (abre una nueva ventana)

Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience. (abre una nueva ventana)

Ruiz-Argüelles GJ, Morales-Toquero A, López-Martínez B, Tarín-Arzaga LD, Manzano C.

Fuente‎: Bone Marrow Transplant 2005;36(8):715-20.

Indexado en‎: PubMed 16113672

DOI‎: 10.1038/sj.bmt.1705126

https://www.ncbi.nlm.nih.gov/pubmed/16113672 (abre una nueva ventana)

Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia. (abre una nueva ventana)

Zwaan CM, Kaspers GJ

Fuente‎: Br J Haematol 2004;127(3):264-79.

Indexado en‎: PubMed 15491285

DOI‎: 10.1111/j.1365-2141.2004.05167.x

https://www.ncbi.nlm.nih.gov/pubmed/15491285 (abre una nueva ventana)

Tratamiento de la leucemia aguda linfoblástica con poliquimioterapia sin hemoderivados en niños Testigos de Jehová​. [Treatment of acute lymphoblastic leukemia using combination chemotherapy without blood-derived products in Jehovah's Witness children. (abre una nueva ventana)

​Tenorio-Guajardo G, Ferrer-Argote VE, Glender-Díaz W, Collazo-Jaloma J

Fuente‎: Rev Med Hosp Gen Mex 2009;72(1):16-9.

Indexado en‎: ISSN 0185-1063

https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=21009 (abre una nueva ventana)